New advances allow scientists to study DNA, RNA, and gene activity in individual cells rather than in bulk tissue samples.

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight ...

T therapy targeting p95HER2 shows complete and durable tumor responses in HER2+ breast cancer preclinical models. Combining ...

How would you summarize your study for a lay audience? T helper (TH) cells are essential immune cells that help other immune ...

The most comprehensive map of the developing human thymus sheds light on how immune responses are built and maintained at early life, with implications for understanding and treating immunodeficiency, ...

Opens in a new tab or window Chimeric antigen receptor (CAR) T-cell therapy has had a transformational impact on the ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

The companies have teamed up to develop Takeda’s proprietary induced pluripotent stem cell (iPSC) derived CAR-T cell ...

The post-HCT environment provides a hostile milieu for adoptively transferred T cells. Development of novel HCT platforms that minimize the need for post-HCT immunosuppression to prevent GVHD and ...

He is in charge of the protein product strategy, including product marketing, product development and product line ...

Allogeneic hematopoietic stem cell transplantation (HCT) is currently the standard of care for most patients with high-risk acute leukemias and some other hematologic malignancies. Although HCT ...